Literature DB >> 22289037

Gold-containing indoles as anticancer agents that potentiate the cytotoxic effects of ionizing radiation.

Sandra Craig1, Lei Gao, Irene Lee, Thomas Gray, Anthony J Berdis.   

Abstract

This report describes the design and application of several distinct gold-containing indoles as anticancer agents. When used individually, all gold-bearing compounds display cytostatic effects against leukemia and adherent cancer cell lines. However, two gold-bearing indoles show unique behavior by increasing the cytotoxic effects of clinically relevant levels of ionizing radiation. Quantifying the amount of DNA damage demonstrates that each gold-indole enhances apoptosis by inhibiting DNA repair. Both Au(I)-indoles were tested for inhibitory effects against various cellular targets including thioredoxin reductase, a known target of several gold compounds, and various ATP-dependent kinases. While neither compound significantly inhibits the activity of thioreoxin reductase, both showed inhibitory effects against several kinases associated with cancer initiation and progression. The inhibition of these kinases provides a possible mechanism for the ability of these Au(I)-indoles to potentiate the cytotoxic effects of ionizing radiation. Clinical applications of combining Au(I)-indoles with ionizing radiation are discussed as a new strategy to achieve chemosensitization of cancer cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22289037      PMCID: PMC3326641          DOI: 10.1021/jm2005942

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  71 in total

Review 1.  High-throughput screening of natural products for cancer therapy.

Authors:  Alan L Harvey; Ian A Cree
Journal:  Planta Med       Date:  2010-07-15       Impact factor: 3.352

Review 2.  Control of cell cycle progression by phosphorylation of cyclin-dependent kinase (CDK) substrates.

Authors:  Randy Suryadinata; Martin Sadowski; Boris Sarcevic
Journal:  Biosci Rep       Date:  2010-03-17       Impact factor: 3.840

Review 3.  Aurora kinase inhibitors as anticancer molecules.

Authors:  Hiroshi Katayama; Subrata Sen
Journal:  Biochim Biophys Acta       Date:  2010-09-20

Review 4.  Epidemiology and the causes of breast cancer.

Authors:  Brian MacMahon
Journal:  Int J Cancer       Date:  2006-05-15       Impact factor: 7.396

5.  Relativistic functional groups: aryl carbon-gold bond formation by selective transmetalation of boronic acids.

Authors:  David V Partyka; Matthias Zeller; Allen D Hunter; Thomas G Gray
Journal:  Angew Chem Int Ed Engl       Date:  2006-12-11       Impact factor: 15.336

Review 6.  From nature to drug discovery: the indole scaffold as a 'privileged structure'.

Authors:  Fernando Rodrigues de Sá Alves; Eliezer J Barreiro; Carlos Alberto Manssour Fraga
Journal:  Mini Rev Med Chem       Date:  2009-06       Impact factor: 3.862

Review 7.  Development of new cancer therapeutic agents targeting mitosis.

Authors:  Mark R Miglarese; Robert O Carlson
Journal:  Expert Opin Investig Drugs       Date:  2006-11       Impact factor: 6.206

Review 8.  Metal toxicity, liver disease and neurodegeneration.

Authors:  Roger F Butterworth
Journal:  Neurotox Res       Date:  2010-04-06       Impact factor: 3.911

9.  Sucrose nonfermenting AMPK-related kinase (SNARK) mediates contraction-stimulated glucose transport in mouse skeletal muscle.

Authors:  Ho-Jin Koh; Taro Toyoda; Nobuharu Fujii; Michelle M Jung; Amee Rathod; R Jan-Willem Middelbeek; Sarah J Lessard; Jonas T Treebak; Katsuya Tsuchihara; Hiroyasu Esumi; Erik A Richter; Jørgen F P Wojtaszewski; Michael F Hirshman; Laurie J Goodyear
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

10.  Megabase chromatin domains involved in DNA double-strand breaks in vivo.

Authors:  E P Rogakou; C Boon; C Redon; W M Bonner
Journal:  J Cell Biol       Date:  1999-09-06       Impact factor: 10.539

View more
  5 in total

1.  A metal-containing nucleoside that possesses both therapeutic and diagnostic activity against cancer.

Authors:  Jung-Suk Choi; Ayan Maity; Thomas Gray; Anthony J Berdis
Journal:  J Biol Chem       Date:  2015-02-24       Impact factor: 5.157

2.  Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.

Authors:  Hui Wang; Soumaya Bouzakoura; Sven de Mey; Heng Jiang; Kalun Law; Inès Dufait; Cyril Corbet; Valeri Verovski; Thierry Gevaert; Olivier Feron; Dirk Van den Berge; Guy Storme; Mark De Ridder
Journal:  Oncotarget       Date:  2017-05-30

Review 3.  Thioredoxin reductase: An emerging pharmacologic target for radiosensitization of cancer.

Authors:  Raghavendra S Patwardhan; Deepak Sharma; Santosh K Sandur
Journal:  Transl Oncol       Date:  2022-01-23       Impact factor: 4.243

4.  Gold(I)-triphenylphosphine complexes with hypoxanthine-derived ligands: in vitro evaluations of anticancer and anti-inflammatory activities.

Authors:  Radka Křikavová; Jan Hošek; Ján Vančo; Jakub Hutyra; Zdeněk Dvořák; Zdeněk Trávníček
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

5.  Mild and Efficient Synthesis of Diverse Organo-AuI -L Complexes in Green Solvents.

Authors:  Fredric J L Ingner; Ann-Cathrin Schmitt; Andreas Orthaber; Paul J Gates; Lukasz T Pilarski
Journal:  ChemSusChem       Date:  2020-03-03       Impact factor: 8.928

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.